WO2003063897A8 - Method of providing prophylaxis for tuberculosis in hiv positive individuals - Google Patents

Method of providing prophylaxis for tuberculosis in hiv positive individuals

Info

Publication number
WO2003063897A8
WO2003063897A8 PCT/IB2003/000207 IB0300207W WO03063897A8 WO 2003063897 A8 WO2003063897 A8 WO 2003063897A8 IB 0300207 W IB0300207 W IB 0300207W WO 03063897 A8 WO03063897 A8 WO 03063897A8
Authority
WO
WIPO (PCT)
Prior art keywords
tuberculosis
hiv positive
positive individuals
providing prophylaxis
prophylaxis
Prior art date
Application number
PCT/IB2003/000207
Other languages
French (fr)
Other versions
WO2003063897A1 (en
Inventor
Bakulesh Mafatlal Khamar
Original Assignee
Bakulesh Mafatlal Khamar
Modi Rajiv Indravadan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bakulesh Mafatlal Khamar, Modi Rajiv Indravadan filed Critical Bakulesh Mafatlal Khamar
Priority to EA200400997A priority Critical patent/EA200400997A1/en
Priority to GB0418776A priority patent/GB2400560A/en
Priority to JP2003563586A priority patent/JP2006502090A/en
Priority to BRPI0307262-2A priority patent/BR0307262A/en
Priority to CA002474794A priority patent/CA2474794A1/en
Priority to APAP/P/2004/003109A priority patent/AP2004003109A0/en
Priority to EP03701636A priority patent/EP1478391A1/en
Publication of WO2003063897A1 publication Critical patent/WO2003063897A1/en
Publication of WO2003063897A8 publication Critical patent/WO2003063897A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Present invention relates to the method providing prophylaxis for tuberculosis in HIV positive individuals. According to present invention, vaccine made from 'Mycobacterium w' (Mw) is found to be useful in providing prophylaxis against tuberculosis in HIV positive individuals.
PCT/IB2003/000207 2002-01-29 2003-01-27 Method of providing prophylaxis for tuberculosis in hiv positive individuals WO2003063897A1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
EA200400997A EA200400997A1 (en) 2002-01-29 2003-01-27 METHOD THAT PROVIDES PREVENTION OF TUBERCULOSIS IN HIV-POSITIVE INDIVIDUALS
GB0418776A GB2400560A (en) 2002-01-29 2003-01-27 Method of providing prophylaxis for tuberculosis in hiv positive individuals
JP2003563586A JP2006502090A (en) 2002-01-29 2003-01-27 Methods providing prevention for tuberculosis in HIV positive individuals
BRPI0307262-2A BR0307262A (en) 2002-01-29 2003-01-27 Method of Providing Tuberculosis Prophylaxis in HIV-Positive Individuals
CA002474794A CA2474794A1 (en) 2002-01-29 2003-01-27 Method of providing prophylaxis for tuberculosis in hiv positive individuals
APAP/P/2004/003109A AP2004003109A0 (en) 2002-01-29 2003-01-27 Method of providing prophylaxis for tuberculosis in HIV positive individuals
EP03701636A EP1478391A1 (en) 2002-01-29 2003-01-27 Method of providing prophylaxis for tuberculosis in hiv positive individuals

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN81/MUM/2002 2002-01-29
IN81MU2002 2002-01-29

Publications (2)

Publication Number Publication Date
WO2003063897A1 WO2003063897A1 (en) 2003-08-07
WO2003063897A8 true WO2003063897A8 (en) 2005-03-31

Family

ID=27638225

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2003/000207 WO2003063897A1 (en) 2002-01-29 2003-01-27 Method of providing prophylaxis for tuberculosis in hiv positive individuals

Country Status (8)

Country Link
EP (1) EP1478391A1 (en)
JP (1) JP2006502090A (en)
AP (1) AP2004003109A0 (en)
BR (1) BR0307262A (en)
CA (1) CA2474794A1 (en)
EA (1) EA200400997A1 (en)
GB (1) GB2400560A (en)
WO (1) WO2003063897A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003209534A1 (en) * 2002-03-08 2003-09-22 Bakulesh Mafatlal Khamar The method of treating tuberculosis
ES2231037B1 (en) 2003-10-31 2005-12-16 Archivel Technologies, Sl USEFUL IMMUNOTHERAPIC AGENT FOR THE COMBINED TREATMENT OF TUBERCULOSIS IN ASSOCIATION WITH OTHER PHARMACOS.
ES2307402B1 (en) * 2006-10-30 2009-09-30 Archivel Farma, S.L. PROFILACTIC VACCINE AGAINST TUBERCULOSIS.
EP2170083A4 (en) * 2007-06-28 2011-09-28 Cadila Pharmaceuticals Ltd Mitogen activated protein kinase modulator

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9219425D0 (en) * 1992-09-14 1992-10-28 Univ London Therapeutic agent and its use
GB8918206D0 (en) * 1989-08-09 1989-09-20 Nat Inst Immunology Tuberculosis vaccine
WO2003075824A2 (en) * 2002-03-08 2003-09-18 Modi, Rajiv, Indravadan Process of manufacturing pharmaceutical composition useful for management of tuberculosis

Also Published As

Publication number Publication date
GB0418776D0 (en) 2004-09-22
CA2474794A1 (en) 2003-08-07
GB2400560A (en) 2004-10-20
AP2004003109A0 (en) 2004-09-30
EA200400997A1 (en) 2005-12-29
JP2006502090A (en) 2006-01-19
WO2003063897A1 (en) 2003-08-07
EP1478391A1 (en) 2004-11-24
BR0307262A (en) 2006-12-19

Similar Documents

Publication Publication Date Title
IL159724A0 (en) A nitrogen oxide generating composition for treatment of nail infections
WO2001007432A3 (en) Aminopiperidine derivatives as antibacterials
EP1160645A3 (en) Method and apparatus for establishing a security policy, and method and apparatus for supporting establishment of security policy
WO2003039470A3 (en) Polyvalent immunogen of hiv
GB0101577D0 (en) Compounds
WO2004027822A3 (en) Oriented nanostructures and methods of preparing
WO2004052783A3 (en) Soluble carbon nanotubes
UA88463C2 (en) Pharmaceutical composition comprising compound i and method of treating hiv infection
AU2003274973A1 (en) Thermostable reverse transcriptases and uses thereof
WO2004015085A3 (en) Method and compositions relating to 5’-chimeric ribonucleic acids
WO2005018560A3 (en) Methods of reducing risk of infection from pathogens
WO2005027836A3 (en) Immunogen
WO2003033557A3 (en) Copolymers containing fluorine, method for the production and use thereof
AU2003286486A1 (en) Methods and compositions for immunization against hiv
WO2003063897A8 (en) Method of providing prophylaxis for tuberculosis in hiv positive individuals
WO2003050137A3 (en) Toll-like receptor 4 mutations
AU2003243765A1 (en) 2,4-disubstituted-pyridine n-oxides useful as hiv reverse transcriptase inhibitors
WO2001060838A3 (en) Aids ancestral viruses and vaccines
WO2005001029A3 (en) Ancestral viruses and vaccines
AU2003255611A1 (en) Novel antiretroviral sulpholipids extracted from spirulinae, method for obtaining same, compositions containing same and use thereof as inhibitors of the hiv virus reverse transcriptase
AU2003231959A1 (en) Method and compound for the prophylaxis or treatment of an immunodeficiency condition, such as aids
WO2006040105A3 (en) Method and device for the production and/or machining of pieces
WO2003075824A3 (en) Process of manufacturing pharmaceutical composition useful for management of tuberculosis
WO2006000009A3 (en) Lamellar iron-iii-oxide
EP1323750A3 (en) Thermoprocessable copolymers of tetrafluorethene, dioxole and vinylether

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref document number: 0418776

Country of ref document: GB

Kind code of ref document: A

Free format text: PCT FILING DATE = 20030127

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2003202725

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 534324

Country of ref document: NZ

Ref document number: 2003563586

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2474794

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: AP/P/2004/003109

Country of ref document: AP

WWE Wipo information: entry into national phase

Ref document number: 2003701636

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 200400997

Country of ref document: EA

WWP Wipo information: published in national office

Ref document number: 2003701636

Country of ref document: EP

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 32/2003 ADD "DECLARATION UNDER RULE 4.17: - OF INVENTORSHIP (RULE 4.17(IV)) FOR US ONLY."

WWW Wipo information: withdrawn in national office

Ref document number: 2003701636

Country of ref document: EP

ENP Entry into the national phase

Ref document number: PI0307262

Country of ref document: BR